Liver cancer
Role of aspirin in Live donor liver transplant(LDLT) in preventing acute cellular rejection(ACR)
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 4: after approval
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 11 Nov 2024. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Amrita Institute of Medical SciencesKochi, KeralaDirections ↗
Registry summary (technical)
Open Label Randomised controlled trial of role of aspirin in Live donor liver transplant(LDLT) in preventing acute cellular rejection(ACR) - Nil
Sponsor: Amrita Institute of Medical sciences
CTRI/2023/07/055081 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 11 Nov 2024 · read by us 5 Nov 2026